Zevenbergen Capital Investments’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $54.4M | Buy |
623,335
+101,782
| +20% | +$8.88M | 1.06% | 28 |
|
2025
Q1 | $35.6M | Buy |
521,553
+134,385
| +35% | +$9.18M | 0.87% | 29 |
|
2024
Q4 | $30.1M | Buy |
387,168
+34,020
| +10% | +$2.65M | 0.61% | 34 |
|
2024
Q3 | $23.7M | Buy |
+353,148
| New | +$23.7M | 0.5% | 39 |
|
2017
Q3 | – | Sell |
-3,286,640
| Closed | -$60.1M | – | 81 |
|
2017
Q2 | $60.1M | Buy |
3,286,640
+598,040
| +22% | +$10.9M | 2.61% | 17 |
|
2017
Q1 | $57M | Sell |
2,688,600
-47,460
| -2% | -$1.01M | 2.62% | 15 |
|
2016
Q4 | $40.8M | Buy |
2,736,060
+603,120
| +28% | +$9M | 1.92% | 20 |
|
2016
Q3 | $46.7M | Buy |
2,132,940
+133,440
| +7% | +$2.92M | 1.92% | 20 |
|
2016
Q2 | $39.7M | Buy |
1,999,500
+886,740
| +80% | +$17.6M | 1.86% | 23 |
|
2016
Q1 | $18.9M | Buy |
+1,112,760
| New | +$18.9M | 0.86% | 36 |
|